CSC, CCA partner to expand Cancer Experience Registry

An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs

A cruel reminder crept in alongside the joy that overcame Shauna Erickson-Abou Zahr and Abdallah Abou Zahr at the birth of their daughter, Nadia Carmel, on Jan. 11.

February 23, 2024

Vol.50 No.08

By Alexandria Carolan

Obituary

Sidney Wolfe, father of “research-based advocacy,” dies at 86

Sidney Wolfe, a physician who co-founded the Health Research Group, and—as a pioneer of “research-based advocacy”—took pharmaceutical companies to task over bad drugs, often shaming federal regulators into changing policies for the benefit of patients, died Jan. 1 in Washington. He was 86.

January 05, 2024

Vol.50 No.01

By Alexandria Carolan

Guest Editorial

Patients are the key to disruptive innovation in cancer. Why aren’t they at the table?

Today’s traditional research model relies on incremental innovation that builds upon the shoulders of other researchers’ work, making small but steady strides. Occasionally, leaps are made by researchers who develop new classes of therapy such as stem cell transplant or CAR-T immunotherapy. But cancer patients may not have the luxury to wait 20 years for the traditional scientific process to evolve for their cancer. They can’t wait for a cure.

Shasqi, Johnson & Johnson expand existing research collaboration

Shasqi, Inc. and Johnson & Johnson Enterprise Innovation Inc. have expanded their ongoing research collaboration.

October 13, 2023

Vol.49 No.38

Drugs & Targets

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Pierre Fabre Laboratories and Vernalis, a fully owned subsidiary of HitGen Inc., established a long-term partnership to identify pre-clinical candidates against oncology targets.

September 29, 2023

Vol.49 No.36

In Brief

Patient Engagement Collaborative calls for applications for members

FDA and CTTI announced a call for applications for new members of the Patient Engagement Collaborative. The PEC is an ongoing, shared forum in which the patient community (PEC members), FDA, and CTTI discuss a variety of topics such as improving communication, education, and patient engagement related to medical product regulation.

July 21, 2023

Vol.49 No.29

CSC, CCA partner to expand Cancer Experience Registry

YOU MAY BE INTERESTED IN

An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs

Sidney Wolfe, father of “research-based advocacy,” dies at 86

Patients are the key to disruptive innovation in cancer. Why aren’t they at the table?

Shasqi, Johnson & Johnson expand existing research collaboration

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Patient Engagement Collaborative calls for applications for members

Renew today!

Subscriber content

Login

CSC, CCA partner to expand Cancer Experience Registry

YOU MAY BE INTERESTED IN

An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs

Sidney Wolfe, father of “research-based advocacy,” dies at 86

Patients are the key to disruptive innovation in cancer. Why aren’t they at the table?

Shasqi, Johnson & Johnson expand existing research collaboration

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Patient Engagement Collaborative calls for applications for members

Login

An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs